Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers discover hereditary protection a factor against depression

17.10.2006
Researchers from Umeå University, Sweden, in collaboration with Antwerp University, Belgium, have found a hereditary factor that is involved in the development of depression. Their study shows that a protein called TPH-2 plays a role in the development of both depression and manic depression.

The signal substance serotonin plays a significant role in brain functions. The level of serotonin in the brain has been shown to affect our emotions and moods.

The serotonin level in the brain is important in protecting against depression. Modern medicines for depression, so-called SSRI medicines (selective serotonin resorption inhibitors), work by raising the level of serotonin in the brain. The protein TPH-2 (brain-specific tryptophan hydroxylase), which is important for the regulation of the serotonin level in the brain, has long been suspected of playing a key role in the development of depression and manic depression.

The study, which was recently completed and is being published in the prestigious journal Archives of General Psychiatry, is based on an examination of what forms of TPH-2 (at the DNA level) are found in healthy individuals compared with the forms found in individuals with recurrent depression and manic depression, respectively.

The different forms of TPH-2 people inherit can result in differing levels of serotonin in the brain, thus providing varying degrees of protection against depression.

This comparison made it possible to show that the TPH-2 forms differed between healthy and affected individuals, which means that TPH-2 is involved in the development of these conditions. Certain forms were more common in healthy individuals, indicating that they have a protective effect against these conditions. There are as yet no clinical trials that have studied different THP-2 forms. All subjects who participated in the study live in northern Sweden.

The discovery of this hereditary protective factor, which is one of many, is a major piece of the puzzle in our understanding of the genesis and treatment of these disorders. Further research and economic resources are required for the discovery to lead to enhanced treatment and help for those affected.

The research has been carried out in a collaborative effort between a Swedish team of scientists under the direction of Professor Rolf Adolfsson and post-doctoral fellow Karl-Fredrik Norrback at the Research Unit of the Psychiatric Clinic in Umeå and the Department of Clinical Science, Section for Psychiatry, at Umeå University and a Belgian team of researchers from Antwerp University led by Professor Jurgen Del Favero and Ann van Den Boogaert, PhD. The study is being published in the prestigious journal Archives of General Psychiatry (Brain-specific tryptophan hydroxylase, TPH2, is associated with unipolar and bipolar disorder in a northern Swedish isolated population, 2006).

Depression is one of the most common disorders in the Western world, and according to the WHO (world Health Organization) it will be the most frequent disease by 2020. Three of ten Swedes experience depression some time during their lives, but it is still largely not known why. It is estimated that some 10 percent suffer from recurrent depression and an equally large group experience mood swings with varying degrees of manic depressive disease.

Despite the fact that these disorders cause a great deal of suffering, increased risk of suicide, and shortened lifetimes, as well as major socio-economic costs for society, the causes of these diseases are still largely a mystery. However, scientists agree that the conditions develop through a combination of heredity and environment, such as stress. Far too few research resources are still being allocated to scientists wishing to study mental health, even though the attitude toward research on mental health is improving.

Bertil Born | alfa
Further information:
http://www.umu.se

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>